# AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)

> **NCT02595255** · — · RECRUITING · sponsor: **Erasme University Hospital** · enrollment: 275 (estimated)

## Conditions studied

- Fertility Preservation
- Lymphoma
- Pediatrics Cancer
- Gonadotropin-releasing Hormone Agonist

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02595255
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-04
- **Primary completion:** 2021-12
- **Final completion:** 2036-12
- **Target enrollment:** 275 (ESTIMATED)
- **Last updated:** 2020-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595255, "AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02595255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*